VANESSA YAN: Open Payments
NPI 1790458883 · ANAHEIM, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,744 in 92 payments from 16 companies in 2025. Trend: 2023 $6,152 · 2024 $9,206 · 2025 $5,744
Speaker / faculty: $3,388Food & beverage: $1,848Consulting: $330Education: $111Travel & lodging: $67
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 17 | $4,094 |
| Neurocrine BioSciences, Inc. | 15 | $421 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $243 |
| Otsuka America Pharmaceutical, Inc. | 7 | $177 |
| Alkermes, Inc. | 7 | $174 |
| ABBVIE INC. | 8 | $152 |
| Lundbeck LLC | 7 | $143 |
| E.R. Squibb & Sons, L.L.C. | 4 | $89 |
| Axsome Therapeutics, Inc. | 3 | $85 |
| Janssen Pharmaceuticals, Inc | 1 | $37 |
Products named: AUSTEDO XR, INGREZZA, REXULTI, CAPLYTA, ARISTADA, VRAYLAR, COBENFY, Auvelity.
Industry payments across CA — which companies pay providers there.
